A cancer clinical trial at HonorHealth gives you the possibility of access to groundbreaking cancer drugs — before they're FDA-approved and available to the public.
A clinical trial explores how new cancer drugs, treatments, diagnostic procedures and therapies work on people.
A clinical trial explores how new cancer drugs, treatments, diagnostic procedures and therapies work on people. Clinical trials are important because:
During a clinical trial, you'll:
A clinical trial is an option at any stage of your cancer journey. In fact, it's recommended that you seek out a clinical trial as soon as you're diagnosed. You don't have to wait until other treatments have failed to enroll in a trial.
Each clinical trial has specific eligibility requirements you must meet before you can participate. An HonorHealth Research Institute nurse navigator will help you make a decision.
A placebo is a substance that looks like medicine but is not. Cancer patients in a clinical trial always receive the best standard treatment available or a new treatment that researchers believe is as good or better.
Only in specific circumstances are cancer patients given placebos in a randomized trial. If a placebo is used, researchers may give patients in the control group a placebo in combination with standard treatment to compare standard treatment alone to standard treatment with a new drug.
Talk with your doctor about some of the risks involved with treatment. For example:
Have an open, honest conversation with your doctor about your options. You may want to ask such questions as:
Participation in clinical trials is optional. Likewise, you may choose to leave a clinical trial at any time. If you plan to stop participating, let the research team know why you're leaving the study.
Before entering a cancer clinical trial, you should know as much as possible about the research study. It's important to ask questions and get answers in language you understand.
Clinical trials can be sponsored by government agencies, pharmaceutical companies, individual physician-investigators and healthcare institutions. Clinical trials also can be sponsored by universities, organizations that develop medical devices, doctor's offices or community clinics.
The U.S. government has strict guidelines and safeguards to protect individuals who choose to participate in clinical trials. Every clinical trial in the U.S. must be approved and monitored by a local Institutional Review Board (IRB) to make sure the risks are as low as possible and are worth any potential benefits.
An IRB is an independent committee of physicians, statisticians, community advocates and others who ensure that a clinical trial is ethical and that the rights of study participants are protected. All institutions that conduct or support biomedical research involving people must, by federal regulation, have an IRB that initially approves and periodically reviews the research.